Doxercalciferol (Winthrop U.S.)
Welcome to the PulseAid listing for the Doxercalciferol drug offered from Winthrop U.S.. This Ergocalciferols [Chemical/Ingredient],Vitamin D2 Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Winthrop U.S. |
NON-PROPRIETARY NAME: | Doxercalciferol |
SUBSTANCE NAME: | DOXERCALCIFEROL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Ergocalciferols [Chemical/Ingredient],Vitamin D2 Analog [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-04-17 |
END MARKETING DATE: | 0000-00-00 |
Doxercalciferol HUMAN PRESCRIPTION DRUG Details:
Item Description | Doxercalciferol from Winthrop U.S. |
LABELER NAME: | Winthrop U.S. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(ug/1) |
START MARKETING DATE: | 2017-04-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0955-1720_a8dd3bc5-71e9-45d7-9efb-7106495c1167 |
PRODUCT NDC: | 0955-1720 |
APPLICATION NUMBER: | NDA020862 |
Other DOXERCALCIFEROL Pharmaceutical Manufacturers / Labelers: